3AGGARWAL B B, HARIKUMAR K B. Potential therapeutic etletqs of curcumin, the anti - inflammato:+ agcnl, against nctlrodcgt+nera- tire, cardiovascular, puhnonat7, metabo|ic, autt)immunc and rrc:,- plastic diseases[ J]. Int J Biochem Cell Bio1,2009, 41:40 -59.
5MIRIYALA S, PANCHATCHARAM M, RENGARAJt I U P. Car dioprotective effects of curcumin [ J] . Ad Expe Med Bi l, 2007, 595:359 -377.
6SINGH U, BARIK A, S1NGH B G, at al. Reactions of rceaetive oxy- gen species (ROS) with eureumin analogues: Slralui'e - aetiviv relationship[ J ]. Fl:e Radical Res,2011,45 (3) :317 - 325.
7HANAI H, SUGIMOTO K. Cureumin has bright prospeels r tile treatment of inflammatory bowel disease [ J ]. Curt Pbarm Des, 2009,15 ( 18 ) :2087 - 2094.
8BENGMARK S. Cureumin, an atoxic antinxidant and natmnl NI"- kappaB, eyclooxygenase- 2, liponxygenasc, anti ioducibh: nitriC" oxide synthase inhibitor: a shield against acute and chnmie diseases [J]. J Parenter Enteral Nutr,2006, 30( 1 ) : 45 -51.
9MACZUREK A, HAGER K, KENKLIES M, at al. Cureumia, an atoxie antioxidant and natural NFkappaB, cyclooxygenase - 2, li- pooxygenase, and indueible nitric' oxide synthase inhibitnr: a shield against anute and chronic diseases[ J]. Adv Drug Deliv Rev,2008. 60( 13/14 ) : 1463 - 1470.
10SHARKEY A M, GARDNER L, HIBY S, ct al. Ki]lcr Ig - llkc re- ceptor expression in uterine NK cells is biased towatxt recognition ot' HLA- C and alters with gestational age [ J ]. J lmmunol,2008, 181:39 -46.
